Gail Naughton - Aug 10, 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Director
Signature
/s/ Dr. Gail K. Naughton
Stock symbol
TXMD
Transactions as of
Aug 10, 2021
Transactions value $
$0
Form type
4
Date filed
8/12/2021, 09:39 PM
Previous filing
Jul 2, 2021
Next filing
Aug 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise +96.9K 96.9K Aug 10, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Options Exercise $0 -96.9K -100% $0.00* 0 Aug 10, 2021 Common Stock 96.9K $0.00 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 10, 2021, the reporting person received 96,864 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021.
F2 Each RSU represented a contingent right to receive one share of issuer common stock upon settlement.
F3 The RSUs vested on June 18, 2021.